As of 2025-11-05, the Relative Valuation of Erytech Pharma SA (ERYP.PA) is 0.21 EUR. This relative valuation is based on P/E multiples. With the latest stock price at 0.50 EUR, the upside of Erytech Pharma SA based on Relative Valuation is -58.5%.
The range of the Relative Valuation is (0.08) - 0.53 EUR.
| Range | Selected | |
| Trailing P/E multiples | 9.6x - 30.0x | 10.0x |
| Forward P/E multiples | 31.6x - 46.1x | 43.3x |
| Fair Price | (0.08) - 0.53 | 0.21 |
| Upside | -116.3% - 6.4% | -58.5% |
| Date | P/E |